`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMIVHSSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`13/353,653
`
`ISSUE DATE
`
`07/30/2013
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`8497304
`
`201270088
`
`1077
`
`513
`
`7590
`
`07/10/2013
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above—identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site http://pair.uspto. gov for additional applicants):
`
`Shirou Sawa, Kobe-shi, JAPAN;
`Shuhei Fujita, Kakogawa, JAPAN;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`Fifi?8sl(1{’e‘l3%’7og)
`
`LUPIN EX 1044
`
`LUPIN EX 1044
`
`Page 1 of 333
`
`

`

`(711111111010 211111513111 11115; 1111111, 11113501111111 11-1111 11111111131111:Net's-1.11): 111311111,
`
`PA RT 13 ~ FEMS) TR.¥§.NSS\1.1".1"Y1‘1L
`
`31111118111111 1851.1'1" 1Eit
`1unlnlissimwr 1111‘ Patents
`P1} 3111: 14511
`«91112111111111‘111, V“ginia 225313414511
`
`01: £1111; (5713—273-2S85
`
`
`
`
`
`
`‘1 11111111211:
`1131311
`25111111111
`111: 11111111131111 when:
`‘3: 1111.1 1111111 1111111111111:
`1
`..
`'Z~
`1111‘. 1S
`.1? 1‘1'i1flemd 91131.1(:“7‘11101‘1‘ 1131:: (11:1121111111).13111111;
`11.11 1131131111111311;
`
`
`1111 1.11;! 1111111111 11,- the cum::1! 1‘111‘1'
`”Messy: 1111111‘w‘k
`1111;111:1111.
`..
`-11 1'111‘11‘11‘
`1
`~<
`111111.\p1‘1‘1111‘111 1111111111113; 1111‘ 1111113111311
`311 1.13 211111 1311111111
`111 11f 111111111‘11111111;
`
`
`111 1111011111}- 111} 1111:011yi11g :1. 1111.11- 11:11:3111‘1111‘111‘1‘. addufi: 11111'11'111 {b} indicating :1 ‘St‘fffilfim:
`1111113111111 11111-313 1:11111‘111‘11 111:1:111' 1'11 111111211311 0111119111».
`31131)}?
`1111111111‘1'111111‘1‘ 1'1‘1‘ 11085113110115.
`
`
`1111‘
`‘1 11.4111111121155911112111111,: 1.111. 1.1111};
`N '
`1.1::- 11s~11 11.»; 1111111121111 111;:
`1‘1 111
`
`
`
`1.1
`11111111111" H155. 11:11:13
`113131111112 hr. 11511‘11 11'.)
`‘
`Hymn-1:15;
`
`
`
`111111111 111‘mvi11g. 1111111
`such 11$ 1‘11}
`Fapal
`{3111:}! 1513111111
`211 p.119.
`1111-8 115 mm lit‘l‘iifil.1111‘ 01' 5113111113. 1'51 Ll.11‘1\1111\\5011
`7.91111“c419 1'11 \iiniling 131‘ Trammisskm- 111-11 111111 1111:. 1.:51111111
`
`
`
`
`.
`331111111 1'33 1111 81112111311:
`
`..
`{11113113.
`1'11 being £11:51111111:
`.. 1:11 1111‘. 11111‘ 1111111: 1111:11 1‘1‘10'11'.
`
`
`f.‘i.‘-R.‘-‘\E-N’I' 1' .{1 Ex
`
`II."
`
`S'S {Na-11‘: 131:: Bin-1'51 1' 11:1 my 11:11:31; 01‘ 1:111:11;
`
`1N‘f1"“1,1'
`
`
`131".111.1111. 1.1ND 1‘31 PON LK. LL13.
`
`
`
`11130 1.3111 111111111. N.W..
`Suite. 4130 1321111
`Washing-(.111, D117. 21.10115- 1503
`
`
`
`FILING: 131x133
`
`FIRST NAME?) .1NY‘1'LN71'")1%
`
` 1‘.PFI..1C'Z.:‘1'§I§CFN NU.
`
`511111311 3:1 \1-‘51
`1'1 1119/2111 '2
`13.1“." " '1 .1153
`
`'1'1'1'1...I‘;01"' 1NVEN'1'11'JN: AQT'
`:3.
`
`
`
`111391N E‘YPE
`
` 1101191113111 1111111111 (.E'NI.}13C‘1')1 ‘N'I'EE'J 5 .1 1'88 $11 5.2111318 (139109$311.1 3
`
`
`
`
`
`
`514-1313301111
`
`
`
`.-'\1'1{.1R‘T§R" (33'
`1 1'.11.351511: 111'1:111'11-‘1-[11'151111511'1: 511111113528 111' 53111113551111} 11f ”11:1:
`
`.1:"'1\.1';I1'11111'11.<; 1:11 1111‘. 9111“!“ fut-1‘11 {jag-1‘. 1301'
`'3.
`
`(37.1111 5133)
`{1} 111“n:111’11.~\‘ of up 11111, wen-118111- [3311.11.11 .1ticvn\1‘\,‘s
`
`111‘‘111‘1‘ 21111111“.
`111' ag‘ms {111. 11111311111111'15.-
`a 1.7111111151 111" can
`.
`Addfi‘is: 1mm 1"“ '
`.
`12.1:1111111111111.
`
`
`
`11
`(7 the namu :1} a :invflfi fig:1; (Inn-151g 115; 3 5511311115."!
`
`
`1111111s1'1111g1131‘1'1
`111111-11.
`'
`.111 "
`.,
`‘
`11111111 1111‘. 111111111 01“ up11':
`
`
`113-112111'11'11'111‘ 1
`111,)11111'11'1'11‘11.
`11111911“ 5 111‘51511;1119.Ii “"9 “1"!“ 1‘
`
`
`
`
`11-1 ‘1.711111ng 01".711'11‘11‘4111111111111-
`
`W’ENQERUTH LENB & PUNACK L 1.. p_
`1 ...................................................................
`'1
`
`-—...................................................................
`1'1
`
`3
`
`'15'115111531) RESIE‘EN'QE171.11," ' ‘1‘171’3‘ 131‘:- 1—‘11111‘1‘151'3 {TSN "1'1 11‘. 131‘1’1'1'iN'1' 11311111 1'.11'1}"PC}
`
`
`
`11 (111 3.131%.“1‘. 1'1; 1111211111111 131-11311; 1111‘. 1i1m‘111111‘111 11:15. 1.111;“ flied 1'11:
`11:11:51.1 1111 . signer 15-1111
`111 1\1‘.~11'111-'1111 11111111183 1111111 111.11 119313111011 1111‘. 1.1310111
`
`
`. "R 21.11.
`.7111
`5. 131111111111 11111 i'111m13;N""01 :1 3111111111111: 11-1 111111;: 1111'.
`41111113111.
`
`
`
`1.31) NNM}: 111 AS51111.“
`.11: (1".11'1’ and 5.1
`'53; 110R {Tffi'if-N'FRY)
`
`Sen§u hAr.a¢v1tzwzi 60., Ltd.
`
`Ssaka. Ja3an
`
`
`
` 1
`the-:11 1111‘. 11111110111111? 1111111111111}; 3 {11118111111va
`111:1.
`'1111' 11111131111113. {1111(2) :er 3:111:511'1111‘11:
`411. 13333111111 111' F6111: $3: (Please 1'1er reapply an}- prnviuursiy paid. issue We 5111111111 aim-11'."
`1‘1?“
`..
`1
`.
`$5.1 1:1111‘ 1‘s
`:1 3‘1 111901113 611010-3111.
`
`”3.1 Public 11111111 1'1" (No 31111111 9.1111111 1111131111111 11111111111211)
`3'1 P11311111»)! by 1111-1111. 1'111'11.171312111-I’Z'FENEFE—L‘w‘s-311-1111111511131'1"
`1:! Adv;1111e 1.11mi
`E1111‘. Uil‘i.‘1'l1|".\f1511-31111» 31111111111111 1.11 111111311“ 1-11111111111 1131;~1a) 15115: 11111111111\ 1'11 1‘11‘11‘11‘11113'
`
`
`m-sip.“1119111 11.1 1313.91.15; '1; 311:1»19:11 N111111111‘1‘1‘11111131‘ 1m 1.1mm mp): 1'11 this im‘m}.
`
`Page 2 of 333
`131111.185 {Rm-z {312.11 1)
`
`P1111: 1111;1-
`1"
`
`Page 2 of 333
`
`

`

`
`
`i 1hr13=1=1
`<.‘(" 31151.13 133 Putin) Status. ($1311111:13:111 indie11
`'J' Am‘rliwmi C‘C‘miunu 511.1C31'1C3mii5' 41311135 Seaj‘.'v"(I'R I ”2"}
`
`
`£3 Appiimni asserting 3111.312 mm;- 31111113. Cc .3? (if-1?. I2?
`
`
`
`: farm 9133.53 P)! I 5 A and 15B '}_. issue
`1115- Sum
`NOTE"; Absent a.Cali-dC'C'.1'1'II31'111im1nI Minn 13'
`
`
`11“: paynwni. 313 111C: mica. C311i1'5'31111131131131.4811:
`' 3311231)
`'01 21111:»: 311.313: 113" apphmmcm abandonment.
`
`
`
`
`NUT 11" #11:
`11311111311111 11-
`. pm: 11131): 111 mien) 31111113 512111325. chucking 11353 box wilt be 33km
`
`113 he :1 311L3L1i'11'.<1t'11'.13'3 1.3.5 lass 1).
`:tnt'HJC331C111 to 1735::m 3'111115'
`.—: a 11.2.
`‘uJ swpiicam changing. 31.: regular and} 5113113136311 fee. 3&1 1113
`NS) IE; (Baking this E3011 1.1111 I3»: 5:113:61? 10 be. :3 nmificn'skm 131' Iowa: 131 61131 1! 1111111 113.3'
`‘
`,
`133.113 01' micro
`11311115“ status. :31. apphmhia.
`
`$531.1ch 131' 1333311 party in
` 1113-; m 311cc 31cI'3'C1K1M:§5=33333:1'43I3C'1'1'ha1'1 1311': appskasst: RFCgictmhzd 21131.23311C1' or 1101-111; 01331.13
`.9 a11.131311
`313.1111.
`M
`em'ai|=wcheek@wenderot'h.com, c-='US
`Cheek, Jr./'
`Date: 20130.::626133036 -04'00'
`
`Bah: _ This mik‘c111m of inf-51'111311311313 if: requimd h
`
`" 1111131.».111131111: 31.11311.- {113113 by liw
`.1438 5.111111 ‘
`
`
`‘
`T'SS’I'O 11315131331513
`nation 1'32 1111511111333 in [shiui'u 131' 1'C1113'13 :1. b;
`
`
`
`I 3 :111d"3': (’I-‘R i 33 1mg milC'C'uon'1s cstimalcd 3C1 311ka3.. munim to complain includiw Min 113;.
`inning. amt
`
`2131 43333313313011. 311113de33111115
`gay-C31 {I {15' I5
`
`
`
`subunums: ms 1'33mg:
`31 3531
`.
`'
`I1rm: will run CI:
`.. upon the. individual C .
`. Am 11111111121132 ~31) 11111 3131311131 of 1
`511111323113 31') cumph'tv
`
`
`
`
`this farm similar suggut 1113 n: 131111113133 his 1x11
`1'11 1.1M be SCm 1'13 1I3C (.11C1 hnbrnmiion UfimCr L 8.1211111! 133d hudC'
`111111; Office. If '\' Iicp12131131C313 C31 {ommC'rCCn I’D
`P ' {4:70.1‘dm 11111131 \3 51333:: new 14..=0 1'33?) M511?
`'1‘} H.135 0R 31.0.‘1H’IJIII'ITI‘H{30.1“ TU .l'EIiS ,.3.?33.)RI.’.SS. 551';‘21)£120 {'533111331
`11333111 {<33 IC';13-::1333.P.U.I>o\ 145.0.
`
`A. 3.1331131111153131: 2-1231 41-533
`finder Lh'C' P1153333 1111'}; Rmhsciion 55111 131' E995. 310. persons 1113:. requimd to 1135;510:131 113 a. CUHCCLiun 0f Inflammation iilflt‘SS it (Eispia'y's a mud [IE/1B C'cmlt'rfi munhm'.
`
` 3.1131111: _
`
`1":11'12398381133‘13333 ,: .Appnwed for 1393:: 3113911511 1313133321113.
`
`Pagc 3 13h:
`033131 1131-5514]. _ : EELS.I’awmaud“1111131112311; Ofiimri i .S 111'PM"[\Ilf‘k! WI {TU\’I_:\/II."1'{I.'.I.'.
`
`
`
`Page 3 of 333
`
`

`

`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`13353653
`
`Filing Date:
`
`19-Jan-2012
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`First Named Inventor/Applicant Name:
`
`Shirou Sawa
`
`Attorney Docket Number:
`
`2012_0088
`
`Filed as Large Entity
`
`Utility under 35 USC111(a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`USD($)
`
`
`
`Basic Filing:
`
`Pages:
`
`Claims:
`
`Miscellaneous-Filing:
`
`Patent-Appeals-and-lnterference:
`
`Post-Al|owance-and-Post-lssuance:
`
`Utility Appl Issue Fee
`
`1501
`
`1780
`
`1780
`
`Paoe 4 of 333
`
`Publ. Fee- Early, Voluntary, or Normal
`
`1504
`
`I
`
`300
`
`300
`
`Page 4 of 333
`
`

`

`Extension-of—Time:
`
`Total in USD (5)
`
`Miscellaneous:
`
`Page 5 of 333
`
`Page 5 of 333
`
`

`

`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`
`
`——
`
`Payment information:
`
`yes—
`Submitted with Payment
`
`CHEEKJR., WARREN M.
`
`Page 6 offihgrye any Additional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`—Authorized User
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Page 6 of 333
`
`

`

`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C. F. R. Section 1. 21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Issue Fee Payment (PTO-85B)
`
`AttachA_IF.pdf
`
`484473
`
`ed745934b56b87a273a9c7c615d0c4eb50-
`06d9
`
`The PDF file has been signed with a digital signature and the legal effect of the document will be based on the contents of the file not the
`digital signature.
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`Sfel 47f5a432a6d9687baa06de349fdce208
`139d
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Page 7 of 333
`
`Page 7 of 333
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`513
`
`7590
`
`06/07/2013
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`511.641.1113..
`
`Washington, DC 20005-1503
`
`
`
`
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 06/07/2013
`
`13/353,653
`
`01/19/2012
`
`Shirou Sawa
`
`201270088
`
`1077
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$ 1780
`
`$300
`
`$0
`
`$2080
`
`09/09/2013
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED.
`SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`Page 8 of 333
`PTOL—85 (Rev. 02/11)
`
`Page 1 0“
`
`Page 8 of 333
`
`

`

`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`PO. Box 1450
`Alexandria, Virginia 22313-1450
`or m (571)-273-2885
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`ap ropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change ofaddFESS)
`
`06/07/2013
`7590
`513
`WENDEROTH, LIND & PONACK, L...LP
`1030 15th St
`t N W
`.
`1‘66 ’
`'
`Su1te 400 East
`
`"
`
`Washlngton, DC 20005-1503
`
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`apers. Each additional paper, such as an assignment or formal drawing, must
`gave its own certificate of mailing or transmission.
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273—2885, on the date indicated below.
`
`(Date)
`
`(Depositorsname)
`(Signature)
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
` F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`13/353,653
`
`01/19/2012
`
`Shirou Sawa
`
`201270088
`
`1077
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$ 1780
`
`$3 00
`
`$0
`
`$2080
`
`09/09/2013
`
`SOROUSH, LAYLA
`
`1627
`
`514—619000
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`
`3 Chan e of correspondence address (or Change of Correspondence
`Address orm PTO/SB/ 122) attached.
`
`3 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03—02 or more recent) attached. Use of a Customer
`Vumber is required.
`
`
`
`2. For printing on the patent front page, list
`(1) the names of up to 3 registered patent attorneys
`or agents OR, alternatively,
`(2) the name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`
`
`
`
`2
`
`3
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`If an assignee is identified below, the document has been filed for
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent.
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) :
`
`'3 Individual
`
`'3 Corporation or other private group entity '3 Government
`
`4a. The following fee(s) are submitted:
`3 Issue Fee
`
`
`
`3 Publication Fee (No small entity discount permitted)
`3 Advance Order — # of Copies
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 A check is enclosed.
`
`3 Payment by credit card. Form PTO—2038 is attached.
`3 The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`
`
`Page 9 of 333
`PTOL—85 (Rev. 02/11)
`
`Page 2 0“
`
`Page 9 of 333
`
`

`

`5. Change in Entity Status (from status indicated above)
`3 Applicant certifying micro entity status. See 37 CFR 1.29
`
`3 Applicant asserting small entity status. See 37 CFR 1.27
`
` 3 Applicant changing to regular undiscounted fee status.
`
`NOTE: Absent a valid certification of Micro Entity Status (see form PTO/SB/ 15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`NOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`NOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`
`NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other than the applicant; a registered attorney or agent; or the assignee or other party in
`interest as shown by the records of the United States Patent and Trademark Office.
`
`Authorized Signature
`
`Typed or printed name
`
`
`Date
`
`Registration No.
`
`This collection of information1s required by 37 CFR 1. 311. The information1s re uired to obtain or retain a benefit by the public which1s to file (and by the USPTO to process)
`an application. Confidentiality1s governedby 35 U.S.C. 122 and 37 CFR 1. 14.Tl1is collection1s estimated to take 12 minutes to complete including gathering, prepar1ng, and
`submitting the completed application form to the USPTO. Time will v
`eendin upon the individual case. Any comments on the amount of time you require to complete
`this form and/or su gestions_ for reducing this burden should be sent to
`eC ief In ormation Officer U.S. Patent and Trademark Office U.S. Department of Commerce P.O.
`Box 1450 Alexandgria, Virg1nia 22313— 1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents P.O. Box 14,50
`Alexandria, Virginia 22313— 1450.
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`PToBagQREQ.mfl33Approved for use through 08/31/2013.
`
`OMB 0651—0033
`
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Page 3 of 4
`
`Page 10 of 333
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
`F {ST NAMED INVENTOR
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`13/353,653
`
`01/19/2012
`
`Shirou Sawa
`
`201270088
`
`1077
`
`513
`
`7590
`
`06/07/2013
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`suite/10013,,
`
`Washington, DC 20005-1503
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 06/07/2013
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment to date is 0 day(s). If the issue fee is paid on the date that is three months after the
`mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (six and a half
`months) after the mailing date of this notice, the Patent Term Adjustment will be 0 day(s).
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information Retrieval
`(PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1—(888)—786—0101 or (571)—272—4200.
`
`Page 11 of 333
`PTOL—85 (Rev. 02/11)
`
`Page 4 of 4
`
`Page 11 of 333
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (PL. 93-579) requires that you be given certain information in connection with
`your submission of the attached form related to a patent application or patent. Accordingly, pursuant to
`the requirements of the Act, please be advised that: (l) the general authority for the collection of this
`information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the
`principal purpose for which the information is used by the US. Patent and Trademark Office is to process
`and/or examine your submission related to a patent application or patent. If you do not furnish the
`requested information, the US. Patent and Trademark Office may not be able to process and/or examine
`your submission, which may result in termination of proceedings or abandonment of the application or
`expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom
`of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of
`records may be disclosed to the Department of Justice to determine whether disclosure of these
`records is required by the Freedom of Information Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting
`evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel
`in the course of settlement negotiations.
`. A record in this system of records may be disclosed, as a routine use, to a Member of Congress
`submitting a request involving an individual, to whom the record pertains, when the individual has
`requested assistance from the Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency
`having need for the information in order to perform a contract. Recipients of information shall be
`required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5
`U.S.C. 552a(m).
`. A record related to an International Application filed under the Patent Cooperation Treaty in this
`system of records may be disclosed, as a routine use, to the International Bureau of the World
`Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`. A record in this system of records may be disclosed, as a routine use, to another federal agency for
`purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy
`Act (42 U.S.C. 218(c)).
`to the Administrator,
`. A record from this system of records may be disclosed, as a routine use,
`General Services, or his/her designee, during an inspection of records conducted by GSA as part of
`that agency's responsibility to recommend improvements in records management practices and
`programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance
`with the GSA regulations governing inspection of records for this purpose, and any other relevant
`(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about
`individuals.
`
`. A record from this system of records may be disclosed, as a routine use, to the public after either
`publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35
`U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a
`routine use, to the public if the record was filed in an application which became abandoned or in
`which the proceedings were terminated and which application is referenced by either a published
`application, an application open to public inspection or an issued patent.
`. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local
`law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or
`regulation.
`
`Page 12 of 333
`
`Page 12 of 333
`
`

`

`
`
`Notice of Allowability
`
`Application No.
`
`13/353,653
`Examiner
`
`Applicant(s)
`
`SAWA ET AL.
`Art Unit
`
`LAYLA sonousn
`
`1627
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application.
`If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. IX This communication is responsive to the amendments made on 5/20/13.
`
`2. I] An election was made by the applicant in response to a restriction requirement set forth during the interview on
`requirement and election have been incorporated into this action.
`
`; the restriction
`
`3. IZI The allowed claim(s) is/are 1 8 9 11-14 and 16-25.
`
`4. IX Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119( )-(d) or (f).
`
`a) IX All
`
`b) [I Some*
`
`c) [I None
`
`of the:
`
`1. El Certified copies of the priority documents have been received.
`
`.
`
`2. IX Certified copies of the priority documents have been received in Application No. 10/525,006.
`
`3. El Copies of the certified copies of the priority documents have been received in this national stage application from the
`
`International Bureau (PCT Rule 17.2( )).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE” of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABAN DONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5. I] A SUBSTITUTE OATH OR DECLARATION must be submitted. Note the attached EXAMINER’S AMENDMENT or NOTICE OF
`INFORMAL PATENT APPLICATION (PTO-152) which gives reason(s) why the oath or declaration is deficient.
`
`6. El CORRECTED DRAWINGS ( as “replacement sheets”) must be submitted.
`(a) I] including changes required by the Notice of Draftsperson’s Patent Drawing Review ( PTO-948) attached
`
`1) El hereto or 2) [I to Paper No./Mai| Date
`
`.
`
`(b) I] including changes required by the attached Examiner’s Amendment / Comment or in the Office action of
`Paper No./Mai| Date
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawings in the front (not the back) of
`each sheet. Replacement sheet(s) should be labeled as such in the header according to 37 CFR 1.121(d).
`
`7. El DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner’s comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. I] Notice of References Cited (PTO-892)
`
`2. I] Notice of Draftperson‘s Patent Drawing Review (PTO-948)
`
`3. I] Information Disclosure Statements (PTO/SB/08),
`Paper No./Mai| Date
`4. I] Examiner‘s Comment Regarding Requirement for Deposit
`of Biological Material
`
`5. El Notice of Informal Patent Application
`
`6. [Z Interview Summary (PTO-413),
`Paper No./Mai| Date 5/21/13.
`7. El Examiner‘s Amendment/Comment
`
`8. [Z Examiner‘s Statement of Reasons for Allowance
`
`9. El Other
`
`US. Patent and Trademark Office
`
`PTOL-37 (Rev. 03-11)
`
`Page 13 of 333
`
`Notice of Allowability
`
`Part of Paper No./Mai| Date 20130430
`
`Page 13 of 333
`
`

`

`
`
`Application No.
`
`Applicant(s)
`
`
`
`
` _ _ _ _ 13/353,653 SAWA ET AL.
`
`
`Examiner-Initiated Interwew Summary
`_
`_
`Examiner
`Art UnIt
`
`LAYLA SOROUSH
`
`1627
`
`All participants (applicant, applicant’s representative, PTO personnel):
`
`(1) LA YLA SOROUSH.
`
`(2) Warren Cheek.
`
`Date of Interview: 30 AQI’i/ 2013.
`
`(3)
`
`.
`
`(4)_-
`
`Type:
`
`[I Video Conference
`IZI Telephonic
`I] Personal [copy given to: El applicant
`
`El applicant’s representative]
`
`Exhibit shown or demonstration conducted:
`
`If Yes, brief description:
`
`[I Yes
`
`[I No.
`
`Issues Discussed D101 D112 D102 D103 DOthers
`(For each of the checked b0x(es) above, please describe below the issue and detailed description of the discussion)
`
`
`
`
`
`Claim(s) discussed:
`
`Identification of prior art discussed:
`
`Substance of Interview
`(For each issue discussed, provide a detailed description and indicate if agreement was reached. Some topics may include: identif